Preparation of piperazine derivatives as 5-HT7 receptor antagonists

被引:29
作者
Yoon, Juhee [1 ]
Yoo, Eun A. [1 ]
Kim, Ji-Yeon [1 ]
Pae, Ae Nim [2 ]
Rhim, Hyewhon [2 ]
Park, Woo-Kyu [3 ]
Kong, Jae Yang [3 ]
Choo, Hea-Young Park [1 ]
机构
[1] Ewha Womans Univ, Sch Pharm, Seoul 120750, South Korea
[2] Korea Inst Sci & Technol, Biochem Res Ctr, Seoul 130650, South Korea
[3] Korea Res Inst Chem Technol, Pharmaceut Screening Res Team, Taejon 305343, South Korea
关键词
5-HT7 receptor antagonists; piperazine; sulfonamide; 5-HT2c receptor antagonists;
D O I
10.1016/j.bmc.2008.04.023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Twenty-four compounds of 4-methoxy-N-[3-(4-substituted phenyl-piperazine-1-yl) propyl] benzene sulfonamides and N-[3-(4- substituted phenyl-piperazine-1-yl) propyl] naphthyl sulfonamides were prepared and evaluated as 5-HT7 receptor antagonists. Most of the compounds showed the IC50 values of 12-580 nM. Four methyl branched analogues were also obtained, but the activity for methyl branched analogues was almost same as its straight chain congeners. Among the synthesized compounds, 3c showed a good activity on 5-HT7 receptors and a good selectivity on 5-HT1a, 5-HT2a, 5-HT2c, and 5-HT6 receptors. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5405 / 5412
页数:8
相关论文
共 19 条
[1]  
ATKINSON PJ, 2000, BRIT J PHARMACOL, V129, P132
[2]  
BARD JA, 1993, J BIOL CHEM, V268, P23422
[3]   Recent advances in selective serotonergic agents [J].
Childers, WE ;
Robichaud, AJ .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 :17-33
[4]  
FOBES IT, 1998, J MED CHEM, V41, P655
[5]   5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern [J].
Hedlund, PB ;
Huitron-Resendiz, S ;
Henriksen, SJ ;
Sutcliffe, JG .
BIOLOGICAL PSYCHIATRY, 2005, 58 (10) :831-837
[6]   Molecular, pharmacological and functional diversity of 5-HT receptors [J].
Hoyer, D ;
Hannon, JP ;
Martin, GR .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 71 (04) :533-554
[7]   New tetrahydrobenzindoles as potent and selective 5-HT7 antagonists with increased in vitro metabolic stability [J].
Kikuchi, C ;
Suzuki, H ;
Hiranuma, T ;
Koyama, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (01) :61-64
[8]  
KINKUCHI C, 1999, J MED CHEM, V42, P533
[9]  
LATTMANN E, 2005, Patent No. 2005005387
[10]   Serotonin7 receptors (5-HT7Rs) and their ligands [J].
Leopoldo, A .
CURRENT MEDICINAL CHEMISTRY, 2004, 11 (05) :629-661